Drug Price Trends for LEVONOR-ETH ESTRAD

Average Pharmacy Cost for LEVONOR-ETH ESTRAD

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
LEVONOR-ETH ESTRAD 0.1-0.02 MG	00378-7287-85	0.14726	EACH	2025-02-19
LEVONOR-ETH ESTRAD 0.1-0.02 MG	68180-0854-71	0.14726	EACH	2025-02-19
LEVONOR-ETH ESTRAD 0.1-0.02 MG	68180-0854-73	0.14726	EACH	2025-02-19
LEVONOR-ETH ESTRAD 0.1-0.02 MG	31722-0944-32	0.14726	EACH	2025-02-19
LEVONOR-ETH ESTRAD TRIPHASIC	68180-0857-73	0.34029	EACH	2025-02-19

Market Analysis and Price Projections for Levonorgestrel-Ethinyl Estradiol

Introduction

Levonorgestrel and ethinyl estradiol, commonly combined in oral contraceptives, are widely used for birth control, emergency contraception, and managing abnormal uterine bleeding. This article delves into the market analysis and price projections for this combination drug.

Market Size and Growth

The global levonorgestrel market, which includes the combination with ethinyl estradiol, has been growing steadily. As of 2024, the market size was valued at USD 0.052 billion. Projections indicate that the market is expected to reach USD 0.068 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 3.3% during this period[3].

Driving Factors

Several factors are driving the growth of the levonorgestrel market:

• Increasing Awareness: Greater awareness among people about the benefits of hormonal contraceptives is a significant driver.
• Utilization During Menopause: The use of levonorgestrel in hormone replacement therapy during menopause is also contributing to market growth[3].

Key Players

The levonorgestrel market is dominated by several major pharmaceutical companies, including:

• Bayer
• Paladin Labs
• Foundation Consumer Healthcare
• Theramex (Teva)
• Pfizer
• Apotex
• HRA Pharma[3].

Clinical Use and Efficacy

Levonorgestrel and ethinyl estradiol are used in various formulations, including extended-cycle and continuous-use oral contraceptives. For example, Seasonale®, which combines 0.15 mg of levonorgestrel with 0.03 mg of ethinyl estradiol, is taken for 84 days followed by a 7-day hormone-free interval. This regimen has shown to reduce the incidence of headaches but may increase breakthrough bleeding and spotting events[1].

Side Effects and User Experiences

User reviews highlight a mixed bag of experiences:

• Some users report positive outcomes such as regular periods, lighter menstrual flow, and improved skin[4].
• Others experience side effects like breakthrough bleeding, anxiety, depression, and decreased sex drive[4].

Pricing and Cost Analysis

The cost of levonorgestrel and ethinyl estradiol varies based on the formulation and quantity:

• Extended Cycle 30 mcg-0.15 mg: The cost for a supply of 273 tablets can range from $134 to $170, depending on the pharmacy and any discounts applied[5].
• Biphasic Extended Cycle: Prices can range from $170.65 for 182 tablets to $311.63 for different dosages[5].
• Discounts and Coupons: Various discount programs and coupons, such as those offered by BuzzRx, can significantly reduce the cost, with savings up to 80%[2].

Price Projections

Given the steady growth in the market, prices are likely to remain competitive. However, several factors could influence future pricing:

• Market Competition: Increased competition among pharmaceutical companies may lead to lower prices.
• Regulatory Changes: Changes in healthcare policies or regulations could impact pricing.
• Demand and Supply: Fluctuations in demand and supply, including stock shortages, can affect prices[5].

Consumer Impact

For consumers, the affordability of levonorgestrel and ethinyl estradiol is crucial. The availability of discount programs and coupons can make these medications more accessible. Here is a highlight from a user review:

"I was VERY wary about being switched to this birth control... But after reading a lot of reviews of side effects, I was super worried I'd end up with worse acne. It's been 4 months and I LOVE THIS PILL. My skin has never looked better. I didn't experience any emotional issues with the switch. My period is regular again and lighter than it even was on the other pill." - Ann, Drugs.com[4]

Conclusion

The market for levonorgestrel and ethinyl estradiol is poised for continued growth, driven by increasing awareness and utilization. While prices vary, discounts and coupons can make these essential medications more affordable. As the market evolves, consumers can expect competitive pricing and a range of options to meet their needs.

Key Takeaways

• The global levonorgestrel market is projected to reach USD 0.068 billion by 2032.
• Key drivers include increasing awareness and utilization during menopause.
• Major pharmaceutical companies dominate the market.
• Clinical use includes various formulations with mixed user experiences.
• Pricing varies widely, with discounts available to reduce costs.
• Future prices will be influenced by market competition, regulatory changes, and demand-supply dynamics.

FAQs

1. What is the projected market size for levonorgestrel by 2032?

The global levonorgestrel market is expected to reach USD 0.068 billion by 2032[3].

2. What is the CAGR for the levonorgestrel market?

The levonorgestrel market is expected to exhibit a CAGR of 3.3% by 2032[3].

3. Which companies are major players in the levonorgestrel market?

Major players include Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, and HRA Pharma[3].

4. What are the common side effects of levonorgestrel and ethinyl estradiol?

Common side effects include breakthrough bleeding, spotting, headaches, anxiety, depression, and changes in sex drive[1][4].

5. How can consumers reduce the cost of levonorgestrel and ethinyl estradiol?

Consumers can use discount programs and coupons, such as those offered by BuzzRx, to reduce costs by up to 80%[2].

Sources

1. Cleveland Clinic MedEd: Seasonale® (levonorgestrel 0.15 mg/ethinyl estradiol 0.03 mg) - Selected Clinical Trials.
2. BuzzRx: Levonorgestrel-Eth Estradiol Coupon - Discounts up to 80%.
3. Business Research Insights: Levonorgestrel Market Size, Share | Analysis Report, 2032.
4. Drugs.com: Ethinyl estradiol / levonorgestrel User Reviews & Ratings.
5. Drugs.com: Ethinyl estradiol/levonorgestrel Prices, Coupons, Copay Cards & Patient Assistance.